<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397557167</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164806.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199607  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/oxfordjournals.jbchem.a021383</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/oxfordjournals.jbchem.a021383</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="3">
   <subfield code="a">An Arginine-213 to Glycine Mutation in Human Extracellular-Superoxide Dismutase Reduces Susceptibility to Trypsin-Like Proteinases</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Tetsuo Adachi, Naoaki Morihara, Naoya Yamazaki, Harutaka Yamada, Arao Futenina, Katsumi Kato, Kazuyuki Hirano]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Molecular genetic studies of extracellular-superoxide dismutase (EC-SOD) have shown that individuals with high serum EC-SOD content have a single base substitution generating the exchange of glycine for arginine-213 (R213G) in the heparin-binding domain of this enzyme [Sandström J. et al. (1994) J. Biol. Chem. 269, 19163-19166], which causes the impairment of its binding ability to endothelial cell surface [Adachi T. et al. (1996) Biochem. J. 313, 235-239]. Serum EC-SOD in healthy individuals without the above mutation is heterogeneous with regard to heparin affinity and consists of five fractions, forms (I) to (V), of which (IV) and (V) are the main fractions with high affinity for heparin [AdaChi T. et al. (1995) J. Biochem. 117, 586-590], whereas the major fraction in hemodialysis patients was serum EC-SOD form (I), which is thought to be the proteolytic truncated form. On the other hand, serum EC-SOD in both healthy individuals and hemodialysis patients with the R213G mutation consisted mainly of the high heparin-affinity type. This observation suggests that the susceptibility of EC-SOD to protelnases is reduced by the R213G mutation. The affinity of normal EC-SOD (n-EC-SOD) for heparin decreased by the treatment with trypsin, accompanied by a reduction in the molecular mass. The IC50 of trypsin for the heparin affinity of R213G mutant EC-SOD (m-EC-SOD) was 0.15 μg/ml, fivefold that for n-EC-SOD. Heparin affinity of n-EC-SOD was again more susceptible to neutrophils than that of m-EC-SOD. These results suggested that m-EC-SOD is more resistant to trypsin and neutrophil-release trypsin-like protelnases than n-EC SOD, which causes the heparin affinity of serum EC-SOD to differ in individuals with and without the R213G mutation.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© 1996 BY THE JOURNAL OF BIOCHEMISTRY</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Regular Papers</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">extracellular-superoxide dismutase</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">hemodialysis patient</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">heparin</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">neutrophil</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">trypsin</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Adachi</subfield>
   <subfield code="D">Tetsuo</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Morihara</subfield>
   <subfield code="D">Naoaki</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Yamazaki</subfield>
   <subfield code="D">Naoya</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Yamada</subfield>
   <subfield code="D">Harutaka</subfield>
   <subfield code="u">First Department of Internal Medicine, Aichi Medical University Aichi 480-11</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Futenina</subfield>
   <subfield code="D">Arao</subfield>
   <subfield code="u">First Department of Internal Medicine, Aichi Medical University Aichi 480-11</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kato</subfield>
   <subfield code="D">Katsumi</subfield>
   <subfield code="u">First Department of Internal Medicine, Aichi Medical University Aichi 480-11</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Hirano</subfield>
   <subfield code="D">Kazuyuki</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">The Journal of Biochemistry</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">120/1(1996-07), 184-188</subfield>
   <subfield code="x">0021-924X</subfield>
   <subfield code="q">120:1&lt;184</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">120</subfield>
   <subfield code="o">jbchem</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/oxfordjournals.jbchem.a021383</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">other</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/oxfordjournals.jbchem.a021383</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Adachi</subfield>
   <subfield code="D">Tetsuo</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Morihara</subfield>
   <subfield code="D">Naoaki</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Yamazaki</subfield>
   <subfield code="D">Naoya</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Yamada</subfield>
   <subfield code="D">Harutaka</subfield>
   <subfield code="u">First Department of Internal Medicine, Aichi Medical University Aichi 480-11</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Futenina</subfield>
   <subfield code="D">Arao</subfield>
   <subfield code="u">First Department of Internal Medicine, Aichi Medical University Aichi 480-11</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kato</subfield>
   <subfield code="D">Katsumi</subfield>
   <subfield code="u">First Department of Internal Medicine, Aichi Medical University Aichi 480-11</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Hirano</subfield>
   <subfield code="D">Kazuyuki</subfield>
   <subfield code="u">Department of Pharmaceutics, Gifu Pharmaceutical University Gifu 502</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">The Journal of Biochemistry</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">120/1(1996-07), 184-188</subfield>
   <subfield code="x">0021-924X</subfield>
   <subfield code="q">120:1&lt;184</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">120</subfield>
   <subfield code="o">jbchem</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
